Search

Author/Creator Piris-Villaespesa, M.

1. P1049: A PHASE 2 STUDY OF BEZUCLASTINIB (CGT9486), A NOVEL, HIGHLY SELECTIVE, POTENT KIT D816V INHIBITOR, IN ADULTS WITH ADVANCED SYSTEMIC MASTOCYTOSIS (APEX): METHODS, BASELINE DATA, AND EARLY INSIGHTS. (23rd June 2022)

Authors:
DeAngelo, D. J.; Pullarkat, V.; Piris-Villaespesa, M.; George, T. I.; Patel, J. L.; Ustun, C.; Bose, P.; Heaney, M. L.; Pilla, A.; Massaro, M.; Exter, B.; Jolin, H. A.; Mikhak, Z.; Tashi, T.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
939
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Topic: AS07-Singular Entities/Subtypes/AS07a-ARCH, CCUS, ICUS: CLINICAL AND CARDIOVASCULAR RISK ASSESSMENT OF SUBJECTS WITH JAK2-V617F CLONAL HEMATOPOIESIS. (May 2023)

Authors:
Garrido, S.; López-Cadenas, F.; García-Ávila, S.; Tazón-Vega, B.; Blanco, A.; Palomo, L.; Piris-Villaespesa, M.; García-Gutiérrez, V.; De Vilar, M.; Sola, M.; Yordi, A. Molero; González, A. Pérez; Restrepo, J.; Fox, L.; Saumell, S.; Novoa, S.; Gallur, L.; Salamero, O.; Oristrell, G.; Castellví, J.
Journal:
Leukemia research
Issue:
Volume 128(2023)Supplement
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search